Levalbuterol HCL Solution
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| SPE2D221R0116 | Levalbuterol HCL Solution | |
| Synopsis | ||
|
Modification exercising of 3rd year option. .... Read More |
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| DEFENSE LOGISTICS AGENCY | Combined Synopsis/Solicitation | |
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| SPE2D221R0116 | Levalbuterol HCL Solution | |
| Synopsis | ||
|
Levalbuterol HCL Solution .... Read More
|
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| DEFENSE LOGISTICS AGENCY | Combined Synopsis/Solicitation | |
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| SPE2D221R0116 | Levalbuterol HCL Solution | |
| Synopsis | ||
|
Amendment 0005 is issued to extend the closing date from April 04, 2022 to April 18, 2022 3:00 PM EDT (Eastern Daylight Time) Amendment 0004 is issued to extend the closing date from March 21, 2022 to April 04, 2022 3:00 PM EDT (Eastern Daylight Time) Amendment 0003 is issued to add the 30 count Vials per case to subject solicitation and amend solicitation pages as an attachment. Amendment 0002 is issued to extend the closing date from March 07, 2022 to March 21, 2022 3:00 PM EDT (Eastern Daylight Time) Amendment 0001 issued to solicitation for SPE2D2-21-R-0116 Levalbuterol HCL Solution to add (MG) Milligrams to the unit item description. SPE2D2-21-R-0116 Levalbuterol HCL Solution Solicitation .... Read More |
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| DEFENSE LOGISTICS AGENCY (DLA) | Combined Synopsis/Solicitation | |
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| SPE2D221R0116 | Levalbuterol HCL Solution | |
| Synopsis | ||
|
Amendment 0004 is issued to extend the closing date from March 21, 2022 to April 04, 2022 3:00 PM EDT (Eastern Daylight Time) Amendment 0003 is issued to add the 30 count Vials per case to subject solicitation and amend solicitation pages as an attachment. Amendment 0002 is issued to extend the closing date from March 07, 2022 to March 21, 2022 3:00 PM EDT (Eastern Daylight Time) Amendment 0001 issued to solicitation for SPE2D2-21-R-0116 Levalbuterol HCL Solution to add (MG) Milligrams to the unit item description. SPE2D2-21-R-0116 Levalbuterol HCL Solution Solicitation .... Read More |
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| DEFENSE LOGISTICS AGENCY (DLA) | Combined Synopsis/Solicitation | |
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| SPE2D221R0116 | Levalbuterol HCL Solution | |
| Synopsis | ||
|
Amendment 0003 is issued to add the 30 count Vials per case to subject solicitation and amend solicitation pages as an attachment. Amendment 0002 is issued to extend the closing date from March 07, 2022 to March 21, 2022 3:00 PM EDT (Eastern Daylight Time) Amendment 0001 issued to solicitation for SPE2D2-21-R-0116 Levalbuterol HCL Solution to add (MG) Milligrams to the unit item description. SPE2D2-21-R-0116 Levalbuterol HCL Solution Solicitation .... Read More |
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| DEFENSE LOGISTICS AGENCY (DLA) | Combined Synopsis/Solicitation | |
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| SPE2D221R0116 | Levalbuterol HCL Solution | |
| Synopsis | ||
|
Amendment 0002 is issued to extend the closing date from March 07, 2022 to March 21, 2022 3:00 PM EDT (Eastern Daylight Time) Amendment 0001 issued to solicitation for SPE2D2-21-R-0116 Levalbuterol HCL Solution to add (MG) Milligrams to the unit item description. SPE2D2-21-R-0116 Levalbuterol HCL Solution Solicitation .... Read More |
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| DEFENSE LOGISTICS AGENCY (DLA) | Combined Synopsis/Solicitation | |
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| SPE2D221R0116 | Levalbuterol HCL Solution | |
| Synopsis | ||
|
Amendment 0001 issued to solicitation for SPE2D2-21-R-0116 Levalbuterol HCL Solution, SPE2D2-21-R-0116 Levalbuterol HCL Solution Solicitation .... Read More |
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| DEFENSE LOGISTICS AGENCY (DLA) | Combined Synopsis/Solicitation | |
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| SPE2D221R0116 | Levalbuterol HCL Solution | |
| Synopsis | ||
|
SPE2D2-21-R-0116 Levalbuterol HCL Solution Solicitation .... Read More |
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| DEFENSE LOGISTICS AGENCY (DLA) | Combined Synopsis/Solicitation | |
